Company Overview
About Axsome Therapeutics
Axsome Therapeutics is a pharmaceutical company headquartered in New York, United States, with approximately 201 employees. The company is focused on developing innovative treatments for central nervous system (CNS) conditions, including depression, Alzheimer's disease agitation, migraine, narcolepsy, and fibromyalgia. Axsome's current pipeline includes several investigational drug candidates, such as AXS-05, AXS-07, AXS-12, and AXS-14, which are in various stages of clinical development.
Technologies Used
Key Decision Makers
| Name | Job Title | Contact | |
|---|---|---|---|
Jim Mahoney | Senior Clinical Research Associate | LinkedIn Profile | |
Abby Ansah | Clinical Research Associate II | LinkedIn Profile | |
Michelle Baladi, PhD | Executive Director, Clinical Development | LinkedIn Profile |